eHealth's Soistman plans 37K-share sale in 2026

Rhea-AI Filing Summary

eHealth, Inc. (EHTH) received a Rule 144 notice from Francis S. Soistman Jr. covering a proposed sale of 37,297 shares of common stock through Morgan Stanley Smith Barney LLC, with an intended sale date of 09/01/2026 on NASDAQ. The filer also reports a prior sale of 37,296 common shares on 08/31/2026.

Key Figures

Shares proposed to be sold: 37,297 shares of common stock Aggregate market value of proposed sale: $39,277.47 CUSIP: 32032654 +3 more

6 metrics

Shares proposed to be sold 37,297 shares of common stock Proposed Rule 144 sale through Morgan Stanley Smith Barney LLC on or after 09/01/2026

Aggregate market value of proposed sale $39,277.47 Value of 37,297 common shares covered by the proposed Rule 144 transaction

CUSIP 32032654 CUSIP associated with the eHealth, Inc. common shares in the proposed sale

Planned sale date 09/01/2026 Intended date of Rule 144 sale of 37,297 common shares on NASDAQ

Shares sold in past 3 months 37,296 shares of common stock Reported prior sale on 08/31/2026

Proceeds from past 3-month sale $42,431.66 Total received for 37,296 common shares sold on 08/31/2026

Key Terms

Rule 144, Performance Shares, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Performance Shares financial

"Common | 12/31/2024 | Performance Shares | ISSUER"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 37297 | 39277.47"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does the Form 144 filing for EHTH disclose?

The filing discloses that Francis S. Soistman Jr. has notified of an intended sale of 37,297 eHealth, Inc. common shares under Rule 144, to be executed through Morgan Stanley Smith Barney LLC on or after 09/01/2026 on NASDAQ.

How many EHTH shares are proposed to be sold under this Form 144?

The notice covers a proposed sale of 37,297 shares of eHealth, Inc. common stock. These shares are to be sold through Morgan Stanley Smith Barney LLC, with a stated intended sale date of 09/01/2026 on NASDAQ.

What prior EHTH share sales does Francis S. Soistman Jr. report?

The filer reports a prior sale of 37,296 shares of eHealth, Inc. common stock on 08/31/2026, with total proceeds of $42,431.66 over the past three months, as required disclosure in the Form 144.

Who is the broker for the planned EHTH share sale?

The planned sale of 37,297 eHealth, Inc. common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, as reported in the Form 144 filing.

What is the aggregate market value of the EHTH shares in the planned sale?

The filing states an aggregate market value of $39,277.47 for the 37,297 shares of eHealth, Inc. common stock covered by the planned Rule 144 sale through Morgan Stanley Smith Barney LLC.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 04:20 PM Accepted by SEC EDGAR 09/01/2026 - 04:20 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001233184
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	EHEALTH, INC.
SEC File Number	001-33071
Address of Issuer	9190 PRIORITY WAY WEST DR., SUITE 110 INDIANAPOLIS INDIANA 46240
Phone	737-248-2340
Name of Person for Whose Account the Securities are To Be Sold	FRANCIS S. SOISTMAN JR.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	37297	39277.47	32032654	09/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/31/2024	Performance Shares	ISSUER			37297	12/31/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
FRANCIS S. SOISTMAN JR. 9190 PRIORITY WAY WEST DR., SUITE 110 INDIANAPOLIS IN 46240	Common	08/31/2026	37296	42431.66

144: Remarks and Signature

Remarks
Date of Notice	09/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/01/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Francis Soistman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)